{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:46:17Z","timestamp":1791330377751,"version":"4.3.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.ophtha.2009.06.027","type":"journal-article","created":{"date-parts":[[2009,7,31]],"date-time":"2009-07-31T12:48:26Z","timestamp":1249044506000},"page":"1814-1817","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Diplopia and Fluoroquinolones"],"prefix":"10.1016","volume":"116","author":[{"given":"Frederick W.","family":"Fraunfelder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick T.","family":"Fraunfelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl","key":"10.1016\/j.ophtha.2009.06.027_bib1","doi-asserted-by":"crossref","first-page":"S144","DOI":"10.1086\/428055","article-title":"Antimicrobial safety: focus on fluoroquinolones","volume":"41","author":"Owens","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ophtha.2009.06.027_bib2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2174\/0929867013373435","article-title":"Adverse reactions to fluoroquinolones: an overview on mechanistic aspects","volume":"8","author":"De Sarro","year":"2001","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.ophtha.2009.06.027_bib3","series-title":"2006 Physicians' Desk Reference (PDR)","first-page":"2991","year":"2006"},{"key":"10.1016\/j.ophtha.2009.06.027_bib4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2165\/00002018-199410020-00001","article-title":"Harmonisation in pharmacovigilance","volume":"10","author":"Edwards","year":"1994","journal-title":"Drug Saf"},{"key":"10.1016\/j.ophtha.2009.06.027_bib5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.amjmed.2004.09.015","article-title":"Fluoroquinolone prescribing in the United States: 1995 to 2002","volume":"118","author":"Linder","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.ophtha.2009.06.027_bib6","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0140-6736(88)91627-3","article-title":"Possible exacerbation of myasthenia gravis by ciprofloxacin","volume":"1","author":"Moore","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.ophtha.2009.06.027_bib7","first-page":"1011","article-title":"Toxic optic neuropathy after administration of quinolone derivative","volume":"69","author":"Motolese","year":"1990","journal-title":"Boll Ocul"},{"key":"10.1016\/j.ophtha.2009.06.027_bib8","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/adc.65.10.1165","article-title":"Benign intracranial hypertension after ciprofloxacin administration","volume":"65","author":"Winrow","year":"1990","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.ophtha.2009.06.027_bib9","first-page":"137","article-title":"Drug induced uveitis","volume":"80","author":"Cano Parra","year":"2005","journal-title":"Arch Soc Esp Oftalmol"},{"key":"10.1016\/j.ophtha.2009.06.027_bib10","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.transproceed.2007.01.077","article-title":"Fluoroquinolones-induced tendinitis and tendon rupture in kidney transplant recipients: 2 cases and a review of the literature","volume":"39","author":"Muzi","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ophtha.2009.06.027_bib11","first-page":"516","article-title":"Fluoroquinolone induced tendinopathy: report of 6 cases","volume":"23","author":"Zabraniecki","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ophtha.2009.06.027_bib12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.tox.2005.04.002","article-title":"Fluoroquinolones cause changes in extracellular matrix, signaling proteins, metalloproteinases and caspase-3 in cultured human tendon cells","volume":"212","author":"Sendzik","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.ophtha.2009.06.027_bib13","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1002\/art.10617","article-title":"Ciprofloxacin enhances the stimulation of matrix metalloproteinase 3 expression by interleukin-1beta in human tendon-derived cells: a potential mechanism of fluoroquinolone-induced tendinopathy","volume":"46","author":"Corps","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ophtha.2009.06.027_bib14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s002040000203","article-title":"Ultrastructure of Achilles tendon from rats after treatment with fleroxacin","volume":"75","author":"Shakibaei","year":"2001","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.ophtha.2009.06.027_bib15","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1124\/jpet.103.057984","article-title":"In vitro discrimination of fluoroquinolones toxicity of tendon cells: involvement of oxidative stress","volume":"308","author":"Pouzaud","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ophtha.2009.06.027_bib16","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1046\/j.1365-2125.1999.00016.x","article-title":"Achilles tendinitis associated with fluoroquinolones","volume":"48","author":"van der Linden","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ophtha.2009.06.027_bib17","first-page":"558","article-title":"Fluoroquinolones as etiology of tendinopathy","volume":"55","author":"Gabutti","year":"1998","journal-title":"Ther Umsch"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642009006551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642009006551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:59:10Z","timestamp":1758981550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642009006551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0161642009006551"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2009.06.027","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diplopia and Fluoroquinolones","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2009.06.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}